Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
--
Revenue (TTM)
--
Net Profit (TTM)
--
ROE
--
ROCE
--
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
EV/EBITDA
--
Div. Yield
--
Debt to Equity
--
Book Value
--
EPS
--
Face value
--
Shares outstanding
--
CFO
$2,697.13 Mln
EBITDA
$3,594.01 Mln
Net Profit
$680.10 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Colfax Corporation (CFXA)
| -3.2 | -0.2 | -12.4 | 13.7 | 22.5 | -- | -- |
|
BSE Sensex*
| -15.3 | -11.8 | -15.8 | -5.7 | 6.7 | 7.5 | 11.0 |
|
Company
|
2021
|
2020
|
|---|---|---|
|
Colfax Corporation (CFXA)
| 14.6 | 2.4 |
|
BSE Sensex
| 22.0 | 15.8 |
|
BSE Sensex
| 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies... consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine/life sciences, pipelines, mobile/off-highway equipment, oil, gas, and mining markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent distributors under the DJO brand. Colfax Corporation was founded in 1860 and is based in Wilmington, Delaware. Read more
Co-Founder & Chairman
Mr. Mitchell P. Rales
Pres, CEO & Director
Mr. Matthew L. Trerotola
Headquarters
Wilmington, DE
Website
The share price of Colfax Corporation (CFXA) is $177.71 (NYSE) as of 18-Jan-2022 09:30 EDT. Colfax Corporation (CFXA) has given a return of 22.5% in the last 3 years.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
97.54
|
1.17
|
|
2019
|
-35.30
|
5.41
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
The 52-week high and low of Colfax Corporation (CFXA) are Rs -- and Rs -- as of 02-Apr-2026.
Colfax Corporation (CFXA) has a market capitalisation of $ 4,574 Mln as on 01-Feb-2022. As per SEBI classification, it is a company.
Before investing in Colfax Corporation (CFXA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.